Concord Biotech Ltd. | Mid-cap | Healthcare
₹1,823.50
1.38%
| Concord Biotech Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 12.0B
Gross Profit 8.9B 74.54%
Operating Income 4.5B 37.66%
Net Income 3.7B 30.97%

Balance Sheet Metrics

Total Assets 20.3B
Total Liabilities 2.2B
Shareholders Equity 18.1B
Debt to Equity 0.12

Cash Flow Metrics

Operating Cash Flow 3.0B
Free Cash Flow 1.3B

Revenue & Profitability Trend

Concord Biotech Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 12.0B 10.0B 8.3B 7.1B 6.0B
Cost of Goods Sold 3.1B 2.4B 2.0B 1.8B 1.2B
Gross Profit 8.9B 7.6B 6.3B 5.3B 4.8B
Operating Expenses 2.5B 2.1B 1.9B 1.6B 964.7M
Operating Income 4.5B 3.9B 3.0B 2.4B 3.0B
Pre-tax Income 4.9B 4.1B 3.2B 2.4B 3.1B
Income Tax 1.2B 1.0B 819.3M 625.9M 778.3M
Net Income 3.7B 3.1B 2.4B 1.7B 2.3B
EPS (Diluted) - ₹29.45 ₹22.95 ₹16.72 ₹22.45

Income Statement Trend

Concord Biotech Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 11.4B 9.0B 7.3B 6.3B 6.1B
Non-Current Assets 9.0B 8.0B 7.9B 6.8B 5.8B
Total Assets 20.3B 17.0B 15.1B 13.1B 11.8B
Liabilities
Current Liabilities 1.8B 1.4B 1.9B 1.6B 1.1B
Non-Current Liabilities 374.7M 319.1M 321.4M 544.0M 774.3M
Total Liabilities 2.2B 1.7B 2.2B 2.1B 1.8B
Equity
Total Shareholders Equity 18.1B 15.3B 12.9B 11.0B 10.0B

Balance Sheet Composition

Concord Biotech Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 4.9B 4.1B 3.2B 2.4B 3.1B
Operating Cash Flow 3.0B 3.4B 2.3B 1.8B 2.4B
Investing Activities
Capital Expenditures -1.1B -855.1M -1.5B -1.6B -2.0B
Investing Cash Flow -1.6B -1.6B -1.6B -1.2B -2.0B
Financing Activities
Dividends Paid -915.4M -714.5M -535.6M -705.2M -57.1M
Financing Cash Flow -972.4M -950.7M -796.7M -932.0M 326.2M
Free Cash Flow 1.3B 1.8B 1.0B 519.7M -373.6M

Cash Flow Trend

Concord Biotech Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 50.77
Forward P/E 33.43
Price to Book 10.39
Price to Sales 15.72

Profitability Ratios

Profit Margin 30.97%
Operating Margin 40.90%
Return on Equity 22.26%
Return on Assets 15.13%

Financial Health

Current Ratio 6.17
Debt to Equity 0.16

Per Share Data

EPS (TTM) ₹35.46
Book Value per Share ₹173.28
Revenue per Share ₹114.70

Financial data is updated regularly. All figures are in the company's reporting currency.